Together, we can shape the future of healthcare
We are passionate about advancing science – no matter where it comes from. We identify the best innovations, whether internal or external, and deliver them to patients. Only by partnering with the brightest minds in science and healthcare, can we serve patients with difficult-to-treat diseases, both now and in future.
-
>250 active global partnerships
-
~60% of our R&D pipeline and total Pharma sales involve a partnership
-
140 people worldwide focused on bringing in and managing lasting partnerships
-
51 new agreements in 2025
+20 years of partnering with companies and research institutes globally to advance health 50 years ago, Genentech was born out of a partnership – a collaboration between our co-founder Herb Boyer and his research colleague, Stanley Cohen, which led to the scientific breakthrough of engineering recombinant human DNA into bacteria. Venture capitalist Bob Swanson saw tremendous potential in creating medicines from rDNA. Together, Herb and Bob formed a vision of the incredible impact rDNA could have, which laid the foundation for Genentech and the entire biotechnology industry.
Our breakthroughs often begin with bold thinkers like you—partners who push the boundaries of science, relentlessly focus on solutions for patients beyond the medicines and redefine what’s possible.
We all have a role to play in shaping the future. Together, we can continue to lead the industry through our deep curiosity, teamwork, perseverance, and the bold, trailblazing spirit that leads to life-changing scientific breakthroughs for all patients.